TrialDiabetes care2022

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study.

Maximilian G Posch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.